Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Big Investors
View:
Post by Ingiboy on May 28, 2024 11:55am

Big Investors

Excluding Yofoto, Mainpointe and Jamie McKay it would be interesting to know if all of the other top 10 investors are all aboard on this takeover bid:
Kevin McElwee
David Hall
Peter Lewis
Rolf Hoffman
Ben Austring
Gary Boddington

If they are why ?

What is the structure of Andrew Schutte's new company which is slated to take over Replicel ?  Are any of these shareholders involved ?

Why is this taking so long ?  Has anyone reached out to Odyssey to get an update ?  With this now taking 10 weeks and counting I sense something is not going right.
Be the first to comment on this post